JVSAX
Price
$17.27
Change
-$0.18 (-1.03%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

JVSAX vs VMVAX

Header iconJVSAX vs VMVAX Comparison
Open Charts JVSAX vs VMVAXBanner chart's image
Janus Henderson Small-Mid Cap Value A
Price$17.27
Change-$0.18 (-1.03%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JVSAX vs VMVAX Comparison Chart
Loading...
VS
JVSAX vs. VMVAX commentary
Sep 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVSAX is a Buy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. JVSAX (106M). VMVAX pays higher dividends than JVSAX: VMVAX (2.14) vs JVSAX (0.61). JVSAX was incepted earlier than VMVAX: JVSAX (13 years) vs VMVAX (13 years). JVSAX is a more actively managed with annual turnover of: 62.00 vs. VMVAX (22.00). JVSAX has a lower initial minimum investment than VMVAX: JVSAX (2500) vs VMVAX (3000). JVSAX annual gain was more profitable for investors over the last year : 37.42 vs. VMVAX (25.35). VMVAX return over 5 years is better than : 48.82 vs. JVSAX (32.94).
JVSAXVMVAXJVSAX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years13 years-
Gain YTD20.84514.946139%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets106M30.5B0%
Annual Yield % from dividends0.612.1429%
Returns for 1 year37.4225.35148%
Returns for 3 years34.1820.71165%
Returns for 5 years32.9448.8267%
Returns for 10 years49.01100.8849%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio